Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Status epilepticus.

I E Leppik

    Clinical Therapeutics
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Convulsive status epilepticus requires prompt treatment protocols. Initial therapy involves phenytoin infusion, with lorazepam or diazepam for ongoing seizures, followed by phenobarbital or barbiturate coma if needed.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The effect of topiramate plasma concentration on linguistic behavior, verbal recall and working memory.

    Epilepsy & behavior : E&B·2012
    Same author

    Double-masked, placebo-controlled study of intravenous levetiracetam for the treatment of status epilepticus and acute repetitive seizures in dogs.

    Journal of veterinary internal medicine·2012
    Same author

    Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sex.

    Clinical pharmacology and therapeutics·2012
    Same author

    Zonisamide discontinuation due to psychiatric and cognitive adverse events: a case-control study.

    Neurology·2010
    Same author

    Phenytoin half-life and clearance during maintenance therapy in adults and elderly patients with epilepsy.

    Neurology·2008
    Same author

    Intramuscular, intravenous and oral levetiracetam in dogs: safety and pharmacokinetics.

    Journal of veterinary pharmacology and therapeutics·2008
    Same journal

    Early Feasibility Studies in Europe: A Multisite Qualitative Study of Operational Challenges and Site Selection Determinants at 6 University Hospitals.

    Clinical therapeutics·2026
    Same journal

    Safety of Celecoxib in Elderly Patients With Osteoarthritis: A Real-World Analysis Based on the FAERS Database.

    Clinical therapeutics·2026
    Same journal

    Reimagining Representation Across the Clinical Research Ecosystem: Part II of a Specialty Update on Advancing Diversity, Racial Equity, and Inclusion in Clinical Research.

    Clinical therapeutics·2026
    Same journal

    Combined Effects of Nicorandil and Enhanced External Counterpulsation on Coronary Microcirculation and Exercise Capacity in Patients With Coronary Slow Flow Phenomenon: A Randomized, Controlled, 3-Arm Trial.

    Clinical therapeutics·2026
    Same journal

    Phase 1 Study Evaluating Gefurulimab Pharmacokinetics and Safety Following Delivery Via Autoinjector or Prefilled Syringe With Needle Safety Device in Healthy Adults.

    Clinical therapeutics·2026
    Same journal

    Evaluating Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Associated With Newer Antiseizure Medications Using FAERS and JADER Combined With Bioinformatics Exploration.

    Clinical therapeutics·2026
    See all related articles

    Area of Science:

    • Neurology
    • Emergency Medicine

    Background:

    • Convulsive status epilepticus (CSE) is a critical neurological emergency.
    • Prompt and effective treatment is vital to prevent severe morbidity and mortality.

    Purpose of the Study:

    • To outline a stepwise treatment protocol for managing CSE in emergency settings.
    • To ensure timely and appropriate therapeutic interventions for CSE patients.

    Main Methods:

    • Review and recommendation of established treatment guidelines for CSE.
    • Emphasis on sequential administration of anticonvulsant medications.

    Main Results:

    • Recommended first-line treatment: intravenous phenytoin (20 mg/kg).
    • Second-line options for persistent seizures: intravenous phenobarbital.
  • Refractory cases may require induced barbiturate coma.

    • Conclusions:

    • Standardized emergency room protocols are essential for CSE management.
    • A tiered treatment approach ensures optimal patient outcomes in CSE emergencies.